Scopus (CiteScore 2022 =3.0, Q3) , ISC

Document Type : Original Research Article

Authors

1 Faculty of Education, Van Yuzuncu Yıl University, Van, Turkey

2 Department of Mathematics, Iran University of Science and Technology (IUST) Narmak, 16844, Tehran, Iran

Abstract

Computing topological indices of drug structures provides the chemical information about the underlying topology of the drug’s structures. Novel anticancer drug studies have been conducting by researches to design and produce ideal drugs. Chemical properties of these new drug candidates investigated using the simulation methods. Topological indices also have been used to investigate the chemical properties of some drug structures. Ve-degree and Ev-degree topological indices have been defined recently in chemical graph theory. In this study we evaluated the ev-degree and ve-degree topological indices of some newly defined anticancer drug candidates which are based on alkylating agent.

Graphical Abstract

Ve-degree and Ev-degree topological analysis of some anticancer drugs

Keywords

[1] S. Nada, A.E.F. El Atik, M. Atef. Math. Meth. Appl. Sci. 2018, 41, 5801-5810.
[2] B. Zhao, H. Wu. Appl. Math. Non. Sci. 2017, 2, 93–110.
[3] W. Gao, M.R. Farahani, L. Shi. Acta Med. Med. 2016, 32, 579–585.
[4] W. Gao, M.K. Siddiqui, M. Imran, M.K. Jamil, M.R. Farahani, Saudi Pharm. J. 2016, 24, 258– 264.
[5] W. Gao, W.F. Wang, M.R. Farahani. J. Chem. 2016, Article ID 3216327 (8p).
[6] W. Gao, Y. Wang, W. Wang, L. Shi, Saudi Pharm. J. 2017, 25, 548-555.
[7] W. Gao, Y. Wang, B. Basavanagoud, M.K. Jamil. Saudi Pharm. J. 2017, 25, 580-586.
[8] M. Chellali, T.W. Haynes, S.T. Hedetniemi, T.M. Lewis. Disc. Math. 2017, 340, 31-38.
[9] S. Ediz. Int. J. Sys. Sci. Appl. Math. 2017, 2, 87-92.
[10] S. Ediz. Int. J. Comp. Sci. Math., 2018, 9, 1-12.
[11] S. Ediz, Celal Bayar Üniv. J. Sci. 2017, 13, 615-618.
[12] F. Keshavarz, D. Mohammad-Aghaie. Phys. Chem. Res. 2015, 3, 125-143.
[13] I. Mullaney. Pharmacology in One Semester, 2012.
[14] M.J. Van Maanen, I.M. Tijhof, J.M.A. Damen, C. Versluis, J.J.K. Van den Bosch, Cancer Res. 1999, 59, 4720-4725.
[15] M.J. Van Maanen, K. Doesburg Smits, J.M.A. Damen, A.J.R. Heck. Int. J. Pharma. 2000, 200, 187-194.
[16] M.J. Van Maanen, C.J.M. Smeets, J.H. Beijnen, Can. Treat. Rev. 2000, 26, 257–268.
[17] B. Horoldagva, K.C. Das, T.A. Selenge. Disc. Opti. 2019, 31, 1-7.
[18] P. Żyliński. Aequationes Math. 2019, 93, 735-742.
[19] S. Ediz, M. Cancan. Cur. Com. Aided Drug Design, 2020, 16,190-195.
[20] M. Alaeiyan, C. Natarajan, G. Sathiamoorthy, M.R. Farahani, Eurasian Chem. Commun, 2020, 2, 646-651.
[22] M. Imran, S.A. Bokhary, S. Manzoor, M.K. Siddiqui. Eurasian Chem. Commun, 2020, 2, 680-687.
[23] Z. Ahmad, M. Naseem, M.K. Jamil, Sh. Wang, M.F. Nadeem, Eurasian Chem. Commun, 2020, 2, 712-721.
[24] Z. Ahmad, M. Naseem, M.K. Jamil, M.K. Siddiqui, M.F. Nadeem. Eurasian Chem. Commun, 2020, 2, 663-671.
[25] M. Cancan, S. Ediz, M.R. Farahani, Eurasian Chem. Commun, 2020, 2, 641-645.
[26] A.Q. Baig, M. Naeem, W. Gao, J.B. Liu, Eurasian Chem. Commun, 2020, 2, 634-640.